PoliticalRepoPoliticalRepo

United States · Bill · HR

H.R. 2802 (109th)

Drug Testing Integrity Act of 2005

referredUnited States· United States Congress· EN

Introduced

8 June 2005

Last action

Status

Referred to the Subcommittee on Commerce, Trade and Consumer Protection.

Sponsors

Subjects

Discovery layer

Source updated

15 August 2025

Summary

Drug Testing Integrity Act of 2005 - Declares it is unlawful to: (1) knowingly manufacture, market, sell, ship, or otherwise provide to another individual any product with the intent to assist the use of such product to defraud a drug test (that is, to submit a substance that purports to be from an individual other than its actual source, or purports to have been excreted or collected other than when it was actually excreted or collected); or (2) engage in any other conduct with the intent to produce a false or misleading outcome of a test for the presence of a controlled substance. Grants the Federal Trade Commission enforcement powers as a violation of an unfair or deceptive act or practice.

This text is taken from the official record. PoliticalRepo does not editorialize.

Timeline

No timeline events have been ingested for this record yet.

Votes

No vote records are attached yet.

Versions

No version snapshots stored. Document URLs remain at the source.

Documents

3 official files

Introduced in House (text)

View fileDownload file

Sponsors

No sponsors or actors listed by the source.

Related records

No cross-record relationships stored yet.

Sources

PoliticalRepo is an index and interpretation layer, not the authoritative legal source.